Chelsea Counsel Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82K | Hold |
102
| – | – | ﹤0.01% | 193 |
|
|
2025
Q1 | $2.89K | Sell |
102
-6,757
| -99% | -$192K | ﹤0.01% | 190 |
|
|
2024
Q4 | $285K | Sell |
6,859
-545
| -7% | -$22.7K | 0.15% | 85 |
|
|
2024
Q3 | $495K | Sell |
7,404
-635
| -8% | -$42.4K | 0.24% | 68 |
|
|
2024
Q2 | $955K | Buy |
8,039
+4,005
| +99% | +$476K | 0.48% | 43 |
|
|
2024
Q1 | $430K | Sell |
4,034
-198
| -5% | -$21.1K | 0.24% | 62 |
|
|
2023
Q4 | $421K | Sell |
4,232
-1,550
| -27% | -$154K | 0.22% | 72 |
|
|
2023
Q3 | $597K | Sell |
5,782
-70
| -1% | -$7.23K | 0.31% | 63 |
|
|
2023
Q2 | $711K | Buy |
5,852
+70
| +1% | +$8.51K | 0.35% | 58 |
|
|
2023
Q1 | $888K | Hold |
5,782
| – | – | 0.43% | 51 |
|
|
2022
Q4 | $1.04M | Sell |
5,782
-420
| -7% | -$75.4K | 0.52% | 47 |
|
|
2022
Q3 | $733K | Sell |
6,202
-50
| -0.8% | -$5.91K | 0.45% | 54 |
|
|
2022
Q2 | $893K | Sell |
6,252
-128
| -2% | -$18.3K | 0.46% | 52 |
|
|
2022
Q1 | $1.1M | Sell |
6,380
-25
| -0.4% | -$4.31K | 0.48% | 47 |
|
|
2021
Q4 | $1.63M | Buy |
+6,405
| New | +$1.63M | 0.7% | 35 |
|